Translational Development Acquisition Corp. · NASDAQ:TDAC

Linden Advisors LP reported a 5.50% stake in Translational Development Acquisition Corp. (Schedule 13G)

Event May 27, 2026 · Filed Jun 2, 2026

Linden Advisors LP reported a 5.50% stake in Translational Development Acquisition Corp., 950,000 shares, as a passive investor on May 27, 2026. Filed Jun 2, 2026 (Schedule 13G).

Stake
5.50%
Shares
950,000
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Linden Capital L.P.5.30%913,482
Linden GP LLC5.30%913,482
Linden Advisors LP5.50%950,000
Siu Min Wong5.50%950,000

Source

View original at SEC

Related